| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/29/2006 | WO2006067847A1 Method of preparing antibody by use of cell having its fucose transporter function inhibited |
| 06/29/2006 | WO2006067311A2 Cdc25 phosphatase inhibitors |
| 06/29/2006 | WO2006067134A1 Combination treatment for multiple sclerosis |
| 06/29/2006 | WO2006067114A1 Sulfonyl amino cyclic derivatives and use thereof |
| 06/29/2006 | WO2006057886A3 2-METHYLENE-19,26,27-TRINOR-(20S)-1α-HYDROXYVITAMIN D3 AND ITS USES |
| 06/29/2006 | WO2006057885A3 17,20(e)-dehydro vitamin d analogs and their uses |
| 06/29/2006 | WO2006040485A3 Macromolecule obtained from a bifidobacterium culture and use thereof for the prevention and treatment of inflammatory rheumatisms |
| 06/29/2006 | WO2006018314A3 Immune stimulatory infant nutrition |
| 06/29/2006 | WO2006002377A3 Optimized dosing with anti-cd4 antibodies for tolerance induction in primates |
| 06/29/2006 | US20060143732 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes |
| 06/29/2006 | US20060142556 Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides |
| 06/29/2006 | US20060142385 Inhibitors of matrix metalloproteinase |
| 06/29/2006 | US20060142380 oxidizing (4-Chloro-2-fluorophenoxy)-6-methyl-2-[4-(methylthio)phenyl]-4H-pyran-4-one with an oxidizer selected from sodim metaperiodate and a mixture of titanium teteraisoperoxide, tert-butyl hydroperoxide and diethyl tartrate; 3-(2,4-Difluorophenoxy)-6-methyl-2-[4-(methylsulfinyl)phenyl]-4H-pyran-4-one |
| 06/29/2006 | US20060142336 N-sulfonylpiperidines as metalloproteinase inhibitors (tace) |
| 06/29/2006 | US20060142309 8-Heteroaryl xanthine adenosine A2B receptor antagonists |
| 06/29/2006 | US20060142306 Bronchodilator agents; respiratory system disorders; skin disorders ; asthma; hypotensive agents |
| 06/29/2006 | US20060142292 Water-soluble phenylpyridazine derivative and medicine containing the same |
| 06/29/2006 | US20060142266 Compounds and their uses |
| 06/29/2006 | US20060142264 Novel amide derivatives |
| 06/29/2006 | US20060142258 Estrogen replacement therapy |
| 06/29/2006 | US20060142235 Method of reducing and treating UVB-induced immunosuppression |
| 06/29/2006 | US20060142229 Methods of treating lupus based on antibody affinity and screening methods and compositions for use thereof |
| 06/29/2006 | US20060142224 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 06/29/2006 | US20060141602 Packaging of positive-strand RNA virus replicon particles |
| 06/29/2006 | US20060141580 Encoding protein with immunomodulatory activity, antiviral activity, and antitumor activity; treating any Type 1 interferon treatable disease including cancer; determining if a patient will respond to interferon treatment; transgenic animals |
| 06/29/2006 | US20060141579 Cytokine zcytor17 ligand polynucleotides |
| 06/29/2006 | US20060141573 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same |
| 06/29/2006 | US20060141080 Extracting crushed plant material Cuminum cyminum with water or 50% aqueous alcoholic solvent; extracting a portion of the aqueous extract with n-butanol, separating -butanol layer and an aqueous layer, evaporating, and freeze drying the aqueous layer |
| 06/29/2006 | US20060140969 Hypoallergenic polypeptides based on fish parvalbumin |
| 06/29/2006 | US20060140954 Novel human protein kinases and protein kinase-like enzymes |
| 06/29/2006 | US20060140937 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 06/29/2006 | US20060140932 Human il-1 beta antagonists |
| 06/29/2006 | US20060140922 Modified by introduction of nucleic acid molecule comprising a nucleic acid sequence encoding granulocyte macrophage-colony stimulating factor (GM-CSF) operably linked to a promoter; contains cancer antigen; immunotherapy |
| 06/29/2006 | US20060140920 Adenoviral vectors encoding an antibody fused to a CD4 extracellular domain |
| 06/29/2006 | US20060140906 Composition comprising cysteamine for improving immunity of animals |
| 06/29/2006 | US20060140905 Chemokine beta-7 variants |
| 06/29/2006 | US20060140872 Novel signaling pathway for the production of inglammatory pain and neuropathy |
| 06/29/2006 | DE102004061503A1 New meta-substituted thiazolidinone compounds are polo-like kinase inhibitors useful to treat cancers, autoimmune-, cardiovascular-, infectious-, nephrological-, nephrological- and neurodegenerative-diseases |
| 06/29/2006 | CA2591757A1 Crystal and salt of 1-cyclopropylmethyl-4-[2-(3,3,5,5)-tetramethylcyclohexyl)phenyl]piperazine |
| 06/29/2006 | CA2591304A1 Compositions and methods relating to anti-igf-1 receptor antibodies |
| 06/29/2006 | CA2591215A1 Cdc25 phosphatase inhibitors |
| 06/29/2006 | CA2590471A1 Combination treatment for multiple sclerosis |
| 06/29/2006 | CA2589367A1 Sulfonyl amino cyclic derivatives and use thereof |
| 06/29/2006 | CA2584295A1 Spiro-2, 4-pyrimidinediamine compounds and their uses |
| 06/28/2006 | EP1674576A1 Recombinant allergen with reduced enzymatic activity |
| 06/28/2006 | EP1674575A2 Ligand for herpes simplex virus entry mediator and methods of use |
| 06/28/2006 | EP1674452A1 Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor |
| 06/28/2006 | EP1674110A1 Inhibition of bradykinin release |
| 06/28/2006 | EP1674084A2 Extended release oral dosage composition |
| 06/28/2006 | EP1673396A1 Use of antibodies for reducing the biological effectiveness of il-6 |
| 06/28/2006 | EP1673087A2 Alkoxy substituted imidazoquinolines |
| 06/28/2006 | EP1562920B1 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
| 06/28/2006 | EP1392330B1 Use of lps for treating intestinal inflammation processes |
| 06/28/2006 | EP1353689B9 Immunizing compositions and methods of use |
| 06/28/2006 | EP1255536B1 Indolinone derivatives for modulation of c-kit tyrosine protein kinase |
| 06/28/2006 | EP1218031B1 Pharmaceutical composition comprising an antigen |
| 06/28/2006 | EP1136077B1 Preparations containing virus-like particles as immunopotentiators administered through the mucosa |
| 06/28/2006 | EP1041990B1 Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine |
| 06/28/2006 | EP0990041B1 Regulation of transcription in mammalian cells and viral replication by a tetracyclin repressor |
| 06/28/2006 | EP0895543B1 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens |
| 06/28/2006 | EP0876143B1 Tumor necrosis factor alpha (tnf-alpha) inhibiting pharmaceuticals |
| 06/28/2006 | EP0832227B9 Method for prolonging the expression of a gene of interest using soluble ctla4 molecules |
| 06/28/2006 | EP0783585B1 DEFFECTIVE RECOMBINANT ADENOVIRUSES WITH INACTIVATED IVa2 GENE |
| 06/28/2006 | EP0675732B1 Use of relaxin in the manufacture of therapeutic agents |
| 06/28/2006 | CN1795206A Galectin 9-inducing factors |
| 06/28/2006 | CN1795027A Composition comprising lactobacilli or bifidobacteria and use thereof |
| 06/28/2006 | CN1795008A Histamine binding compounds for treatment method for disease conditions mediated by neutrophils. |
| 06/28/2006 | CN1795005A Medicine health-care usage of globefish I collagen extration and preparing process thereof |
| 06/28/2006 | CN1792254A Health-care food contg. giant salamander, and its production method |
| 06/28/2006 | CN1792248A Cooked meat with donkey-hide gelatin for health-care, moistening-skin, improving-immunity, benefit to brain and retarding-senium |
| 06/28/2006 | CN1261452C Sugar conjugated material CHB extracted from serum of turtle or/and tortoise, preparation process and application in pharmacy thereof |
| 06/28/2006 | CN1261433C 1,3,8-triaza-spiro[4,5]decan-4-one derivs. as neurokinin receptor antagonists |
| 06/28/2006 | CN1261163C Stabilization of macrolides |
| 06/28/2006 | CN1261162C Process for preparing aqueous extracts of plants and extracts obtained |
| 06/28/2006 | CN1261138C Medicine for increasing immunocompetence of children and its preparing process |
| 06/27/2006 | USRE39151 Process for the preparation and purification of thiol-containing maytansinoids |
| 06/27/2006 | US7067713 C1 Inhibitor produced in the milk of transgenic non-human mammals |
| 06/27/2006 | US7067712 Transgenic animal; animal models; gene expression; skin disorders |
| 06/27/2006 | US7067667 Aminoalkyl-3, 4-dihydroquinoline derivatives as no-synthase inhibitors |
| 06/27/2006 | US7067540 Antiinflammatory agents; antiarthritic agents; antihistamines; sepsis shock; antidiabetic agents; bone disorders |
| 06/27/2006 | US7067539 Cannabinoid receptor ligands |
| 06/27/2006 | US7067538 monocyte chemoattractant protein-1; a bis(phenyl) sulfonyl or sulfonamido ketone or dihydroxy compound; antiinflammatory, anticholesterol, antiarthritic agents; immunotherapy; transplant rejection |
| 06/27/2006 | US7067535 5-Phenylbenzylamine compounds, process for their production and intermediates for their synthesis |
| 06/27/2006 | US7067527 Thienopyridine derivatives, their production and use |
| 06/27/2006 | US7067525 Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same |
| 06/27/2006 | US7067516 Compounds used as antiinflammatory agents and enzyme inhibitors |
| 06/27/2006 | US7067512 Substituted 1,4-benzodiazepines and uses thereof |
| 06/27/2006 | US7067503 17-aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase |
| 06/27/2006 | US7067496 Transplanting into dermis, least one hair follicle that has been modified ex vivo to contain nucleic acid molecule to introduce nucleic acid molecule into mammal |
| 06/27/2006 | US7067484 AL-1 neurotrophic factor treatments |
| 06/27/2006 | US7067480 Compositions and methods of use for anti-inflammatory agents |
| 06/27/2006 | US7067254 Detection of inflammatory response in mammals; obtain cells, culture, incubate with test compound, monitor cell response, compare to control, evaluate for inflammatory response |
| 06/27/2006 | US7067160 Three stage extraction using alcohol solvents |
| 06/27/2006 | US7067114 Delivery of antihistamines through an inhalation route |
| 06/27/2006 | CA2408909C Azabicyclo[3.2.1]octane triazolyl tropane derivatives as ccrs5 modulators |
| 06/22/2006 | WO2006066282A1 DRY CONCENTRATE FOR MAKING DIETETIC SOFT DRINK CONTAINING Fe, BEEBREAD AND VITAMIN C AND ITS PRODUCTION PROCESS |
| 06/22/2006 | WO2006066063A1 Nanoparticulate tacrolimus formulations |
| 06/22/2006 | WO2006065946A1 Pyrid-2-ones useful as inhibitors of tec family protein kinases for the treatment of inflammatory, proliferative and immunologically-mediated diseases |
| 06/22/2006 | WO2006065919A1 Pyridil-substituted spiro-hydantoin compounds and use thereof |
| 06/22/2006 | WO2006065908A1 Crystalline forms of6- [(5s, 9r) -9- (4-cyanophenyl) -3-(3, 5-dichlorophenyl) -1-methyl-2, 4-dioxo-1, 3, 7-triazaspiro [4.4] non-7-yl] nicotinic |